Australia, Nov. 11 -- Crinetics Pharmaceuticals Inc., owns the trademark (2580301) for 'PALSONIFY' till Aug. 25, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use.] and 5 [Pharmaceutical preparations for use in oncology;pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases;pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer;all for human use]
Ty...